Header Logo

Please contact mskhan2@childrensnational.org for any questions. Can't find your name in profiles ? Request a Profile

Last Name

Darbari, Deepika

TitleAssistant Professor
InstitutionChildrens National Medical Center
Address111 Michigan Ave NW
Washington DC 20010
Phone(202) 4766393
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Majumdar S, Tirona R, Mashegu H, Desai J, Shannon NT, Summar M, Cunningham G, Darbari D, Nickel R, Campbell A, Barr FE. A phase 1 dose-finding study of intravenous L-citrulline in sickle cell disease: a potential novel therapy for sickle cell pain crisis. Br J Haematol. 2018 Feb 07. PMID: 29411862.
      View in: PubMed
    2. Vance Utset L, Ivy Z, Willen SM, Rodeghier M, Watt A, Schilling L, Jenkins CL, Pepper S, Speller-Brown B, Darbari DS, Majumdar S, Adisa O, DeBaun MR. Inhaled corticosteroid use to prevent severe vaso-occlusive episode recurrence in children between 1 and 4 years of age with sickle cell disease: a multicenter feasibility trial. Am J Hematol. 2018 Jan 11. PMID: 29322539.
      View in: PubMed
    3. Darbari DS, Brandow AM. Pain-measurement tools in sickle cell disease: where are we now? Hematology Am Soc Hematol Educ Program. 2017 Dec 08; 2017(1):534-541. PMID: 29222302.
      View in: PubMed
    4. Panepinto JA, Paul Scott J, Badaki-Makun O, Darbari DS, Chumpitazi CE, Airewele GE, Ellison AM, Smith-Whitley K, Mahajan P, Sarnaik SA, Charles Casper T, Cook LJ, Leonard J, Hulbert ML, Powell EC, Liem RI, Hickey R, Krishnamurti L, Hillery CA, Brousseau DC. Determining the longitudinal validity and meaningful differences in HRQL of the PedsQLâ„¢ Sickle Cell Disease Module. Health Qual Life Outcomes. 2017 Jun 12; 15(1):124. PMID: 28606098.
      View in: PubMed
    5. Dampier C, Palermo TM, Darbari DS, Hassell K, Smith W, Zempsky W. AAPT Diagnostic Criteria for Chronic Sickle Cell Disease Pain. J Pain. 2017 May; 18(5):490-498. PMID: 28065813.
      View in: PubMed
    6. Neri CM, Beeson T, Mead H, Darbari DS, Meier ER. Provider Perspective on Integrative Medicine for Pediatric Sickle Cell Disease-related Pain. Glob Adv Health Med. 2016 Jan; 5(1):44-50. PMID: 26937313; PMCID: PMC4756782.
    7. Okoye NC, Meier ER, Darbari DS. Hydroxyurea therapy in sickle cell disease: An alternative approach to preoperative red cell transfusion. J Natl Med Assoc. 2015 Jun; 107(2):102-3. PMID: 27269497.
      View in: PubMed
    8. Darbari DS, Hampson JP, Ichesco E, Kadom N, Vezina G, Evangelou I, Clauw DJ, Taylor Vi JG, Harris RE. Frequency of Hospitalizations for Pain and Association With Altered Brain Network Connectivity in Sickle Cell Disease. J Pain. 2015 Nov; 16(11):1077-86. PMID: 26291276; PMCID: PMC4986827 [Available on 11/01/16].
    9. Brousseau DC, Scott JP, Badaki-Makun O, Darbari DS, Chumpitazi CE, Airewele GE, Ellison AM, Smith-Whitley K, Mahajan P, Sarnaik SA, Casper TC, Cook LJ, Dean JM, Leonard J, Hulbert ML, Powell EC, Liem RI, Hickey R, Krishnamurti L, Hillery CA, Nimmer M, Panepinto JA. A multicenter randomized controlled trial of intravenous magnesium for sickle cell pain crisis in children. Blood. 2015 Oct 01; 126(14):1651-7. PMID: 26232172; PMCID: PMC4591790 [Available on 10/01/16].
    10. Sheehy KA, Finkel JC, Darbari DS, Guerrera MF, Quezado ZM. Dexmedetomidine as an Adjuvant to Analgesic Strategy During Vaso-Occlusive Episodes in Adolescents with Sickle-Cell Disease. Pain Pract. 2015 Nov; 15(8):E90-7. PMID: 26205912; PMCID: PMC4670780 [Available on 11/01/16].
    11. Speller-Brown B, Patterson Kelly K, VanGraafeiland B, Feetham S, Sill A, Darbari D, Meier ER. Measuring Transition Readiness: A Correlational Study of Perceptions of Parent and Adolescents and Young Adults with Sickle Cell Disease. J Pediatr Nurs. 2015 Sep-Oct; 30(5):788-96. PMID: 26195300.
      View in: PubMed
    12. Azar JM, Darbari DS, Meier ER, Conklin LS, Darbari A. Inflammatory bowel disease in sickle cell disease: diagnostic and treatment challenges. J Pediatr Gastroenterol Nutr. 2014 Nov; 59(5):e47. PMID: 25347161.
      View in: PubMed
    13. Wallen GR, Minniti CP, Krumlauf M, Eckes E, Allen D, Oguhebe A, Seamon C, Darbari DS, Hildesheim M, Yang L, Schulden JD, Kato GJ, Taylor JG. Sleep disturbance, depression and pain in adults with sickle cell disease. BMC Psychiatry. 2014 Jul 21; 14:207. PMID: 25047658; PMCID: PMC4223647.
    14. Darbari DS, Ballas SK, Clauw DJ. Thinking beyond sickling to better understand pain in sickle cell disease. Eur J Haematol. 2014 Aug; 93(2):89-95. PMID: 24735098.
      View in: PubMed
    15. Arteta M, Campbell A, Nouraie M, Rana S, Onyekwere OC, Ensing G, Sable C, Dham N, Darbari D, Luchtman-Jones L, Kato GJ, Gladwin MT, Castro OL, Minniti CP, Gordeuk VR. Abnormal pulmonary function and associated risk factors in children and adolescents with sickle cell anemia. J Pediatr Hematol Oncol. 2014 Apr; 36(3):185-9. PMID: 24309610.
      View in: PubMed
    16. Belfer I, Youngblood V, Darbari DS, Wang Z, Diaw L, Freeman L, Desai K, Dizon M, Allen D, Cunnington C, Channon KM, Milton J, Hartley SW, Nolan V, Kato GJ, Steinberg MH, Goldman D, Taylor JG. A GCH1 haplotype confers sex-specific susceptibility to pain crises and altered endothelial function in adults with sickle cell anemia. Am J Hematol. 2014 Feb; 89(2):187-93. PMID: 24136375; PMCID: PMC4281092.
    17. Darbari DS, Nouraie M, Taylor JG, Brugnara C, Castro O, Ballas SK. Alpha-thalassaemia and response to hydroxyurea in sickle cell anaemia. Eur J Haematol. 2014 Apr; 92(4):341-5. PMID: 24330217; PMCID: PMC3962692.
    18. Darbari DS, Wang Z, Kwak M, Hildesheim M, Nichols J, Allen D, Seamon C, Peters-Lawrence M, Conrey A, Hall MK, Kato GJ, Taylor JG. Severe painful vaso-occlusive crises and mortality in a contemporary adult sickle cell anemia cohort study. PLoS One. 2013; 8(11):e79923. PMID: 24224021; PMCID: PMC3818240.
    19. Ballas SK, Darbari DS. Neuropathy, neuropathic pain, and sickle cell disease. Am J Hematol. 2013 Nov; 88(11):927-9. PMID: 23963922.
      View in: PubMed
    20. Paul R, Minniti CP, Nouraie M, Luchtman-Jones L, Campbell A, Rana S, Onyekwere O, Darbari DS, Ajayi O, Arteta M, Ensing G, Sable C, Dham N, Kato GJ, Gladwin MT, Castro OL, Gordeuk VR. Clinical correlates of acute pulmonary events in children and adolescents with sickle cell disease. Eur J Haematol. 2013 Jul; 91(1):62-8. PMID: 23560516; PMCID: PMC3689858.
    21. Neri CM, Pestieau SR, Darbari DS. Low-dose ketamine as a potential adjuvant therapy for painful vaso-occlusive crises in sickle cell disease. Paediatr Anaesth. 2013 Aug; 23(8):684-9. PMID: 23565738.
      View in: PubMed
    22. Darbari DS, Desai D, Arnaldez F, Desai K, Kallen J, Strouse J, Streiff MB, Hong K, Takemoto CM. Safety and efficacy of catheter directed thrombolysis in children with deep venous thrombosis. Br J Haematol. 2012 Nov; 159(3):376-8. PMID: 22934795.
      View in: PubMed
    23. Ballas SK, Kesen MR, Goldberg MF, Lutty GA, Dampier C, Osunkwo I, Wang WC, Hoppe C, Hagar W, Darbari DS, Malik P. Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management. ScientificWorldJournal. 2012; 2012:949535. PMID: 22924029; PMCID: PMC3415156.
    24. Darbari DS, Panepinto JA. What is the evidence that hydroxyurea improves health-related quality of life in patients with sickle cell disease? Hematology Am Soc Hematol Educ Program. 2012; 2012:290-1. PMID: 23233594.
      View in: PubMed
    25. Taylor JG, Darbari DS, Darari DS, Maric I, McIver Z, Arthur DC. Therapy-related acute myelogenous leukemia in a hydroxyurea-treated patient with sickle cell anemia. Ann Intern Med. 2011 Nov 15; 155(10):722-4. PMID: 22084346; PMCID: PMC3508679.
    26. Darbari DS, Onyekwere O, Nouraie M, Minniti CP, Luchtman-Jones L, Rana S, Sable C, Ensing G, Dham N, Campbell A, Arteta M, Gladwin MT, Castro O, Taylor JG, Kato GJ, Gordeuk V. Markers of severe vaso-occlusive painful episode frequency in children and adolescents with sickle cell anemia. J Pediatr. 2012 Feb; 160(2):286-90. PMID: 21890147; PMCID: PMC3258348.
    27. Darbari DS, Neely M, van den Anker J, Rana S. Increased clearance of morphine in sickle cell disease: implications for pain management. J Pain. 2011 May; 12(5):531-8. PMID: 21277838; PMCID: PMC3086992.
    28. Niu X, Nouraie M, Campbell A, Rana S, Minniti CP, Sable C, Darbari D, Dham N, Reading NS, Prchal JT, Kato GJ, Gladwin MT, Castro OL, Gordeuk VR. Angiogenic and inflammatory markers of cardiopulmonary changes in children and adolescents with sickle cell disease. PLoS One. 2009 Nov 23; 4(11):e7956. PMID: 19956689; PMCID: PMC2776981.
    29. Gordeuk VR, Campbell A, Rana S, Nouraie M, Niu X, Minniti CP, Sable C, Darbari D, Dham N, Onyekwere O, Ammosova T, Nekhai S, Kato GJ, Gladwin MT, Castro OL. Relationship of erythropoietin, fetal hemoglobin, and hydroxyurea treatment to tricuspid regurgitation velocity in children with sickle cell disease. Blood. 2009 Nov 19; 114(21):4639-44. PMID: 19724057; PMCID: PMC2780300.
    30. Dham N, Ensing G, Minniti C, Campbell A, Arteta M, Rana S, Darbari D, Nouraie M, Onyekwere O, Lasota M, Kato GJ, Gladwin MT, Castro O, Gordeuk V, Sable C. Prospective echocardiography assessment of pulmonary hypertension and its potential etiologies in children with sickle cell disease. Am J Cardiol. 2009 Sep 01; 104(5):713-20. PMID: 19699350; PMCID: PMC3197734.
    31. Darbari DS, Fasano RS, Minniti CP, Castro OO, Gordeuk VR, Taylor JG, Rehm JY. Severe Vaso-Occlusive Episodes Associated with Use of Systemic Corticosteroids in Patients with Sickle Cell Disease. J Natl Med Assoc. 2008 Aug; 100(8):948-951. PMID: 28643632.
      View in: PubMed
    32. Darbari DS, Minniti CP, Rana S, van den Anker J. Pharmacogenetics of morphine: Potential implications in sickle cell disease. Am J Hematol. 2008 Mar; 83(3):233-6. PMID: 17722074.
      View in: PubMed
    33. Darbari DS, van Schaik RH, Capparelli EV, Rana S, McCarter R, van den Anker J. UGT2B7 promoter variant -840G>A contributes to the variability in hepatic clearance of morphine in patients with sickle cell disease. Am J Hematol. 2008 Mar; 83(3):200-2. PMID: 17724700.
      View in: PubMed
    34. Fung EB, Harmatz P, Milet M, Ballas SK, De Castro L, Hagar W, Owen W, Olivieri N, Smith-Whitley K, Darbari D, Wang W, Vichinsky E. Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload. Am J Hematol. 2007 Apr; 82(4):255-65. PMID: 17094096.
      View in: PubMed
    35. Darbari DS, Kple-Faget P, Kwagyan J, Rana S, Gordeuk VR, Castro O. Circumstances of death in adult sickle cell disease patients. Am J Hematol. 2006 Nov; 81(11):858-63. PMID: 16924640.
      View in: PubMed
    36. Darbari D, Loyevsky M, Gordeuk V, Kark JA, Castro O, Rana S, Apprey V, Kurantsin-Mills J. Fluorescence measurements of the labile iron pool of sickle erythrocytes. Blood. 2003 Jul 01; 102(1):357-64. PMID: 12623854.
      View in: PubMed
    Darbari's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    Co-Authors Expand Description
    Similar People Expand Description
    Same Department Expand Description
    Physical Neighbors Expand Description